Exploring the Novel and Innovative Glucagon Formulations for the Treatment of Severe Hypoglycemia

This activity was originally broadcast as a live virtual symposium during the 12^th Annual Directions in Pharmacy conference series.

Program Description

Insulin and glucagon are key hormones involved in the regulation of blood sugar. When blood sugar levels drop below 70 mg/dL, patients can develop symptoms of hypoglycemia, which can include shakiness and dizziness, or loss of consciousness and can be life threatening in more severe cases. Pharmacists have important roles in educating patients about identification, risk factors, and management of severe hypoglycemia to promote hypoglycemia awareness among patients with and without diabetes. This activity will review the pathophysiology, causes, and classifications of hypoglycemia. Recent updates to the American Diabetes Association guidelines related to hypoglycemia treatment and the use of different glucagon formulations in the emergency treatment of hypoglycemia will also be discussed.

Target audience: Retail pharmacists and health-system pharmacists

Type of activity: Knowledge
Release date: June 20, 2022
Expiration date: June 20, 2023

Time to complete activity: 0.75 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Review current American Diabetes Association guidelines related to hypoglycemia treatment
• Discuss the new and emerging formulations of glucagon, including administration, safety, and efficacy of these therapies
• Recognize the role of the pharmacist in patient counseling, preventing clinically significant hypoglycemia, and promoting appropriate use of glucagon in severe hypoglycemia

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.075 CEU) under the ACPE universal activity number 0290-0000-22-309-H01-P. The activity is available for CE credit through June 20, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Jessica L. Kerr, PharmD, CDCES, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff: Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Rose Buszka, PharmD, BCPS; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no financial relationships with commercial interests to disclose.

An anonymous peer reviewer has been used as part of content validation and conflict resolution. The peer reviewer has no financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms